Pediatrics

PCV13 recommended for 6- to 18-year-olds at high risk

(HealthDay)—Pneumococcal conjugate vaccine 13 (PCV13) should be administered to certain children aged 6 through 18 years who are at high risk of invasive pneumococcal disease (IPD), according to a policy statement published ...

Cardiology

How pneumonia bacteria can compromise heart health

Bacterial pneumonia in adults carries an elevated risk for adverse cardiac events (such as heart failure, arrhythmias, and heart attacks) that contribute substantially to mortality—but how the heart is compromised has been ...

Medications

Study finds Pfizer vaccine cuts pneumonia in elderly

Pfizer Inc. said Wednesday that its blockbuster vaccine against pneumonia, blood and other infections met its goal of preventing illness in vulnerable elderly patients in a huge study required by U.S. regulators.

Diseases, Conditions, Syndromes

An ally against childhood pneumonia

(Medical Xpress)—Since 2000, children born in the United States benefit from the research of Keith Klugman, who helped develop the pneumonia vaccine that is now part of their immunization regimen. As a result, invasive ...

page 2 from 3